Drug Information

Drug General Information
Drug ID
D0D7MP
Former ID
DNC013317
Drug Name
(+/-)-oxiran-2-ylmethyl (9Z)-octadec-9-enoate
Drug Type
Small molecular drug
Indication Discovery agent Investigative [529008]
Formula
C21H38O3
Canonical SMILES
CCCCCCCCC=CCCCCCCCC(=O)OCC1CO1
InChI
1S/C21H38O3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-21(22)24-19-20-18-23-20/h9-10,20H,2-8,11-19H2,1H3/b10-9-
InChIKey
VWYIWOYBERNXLX-KTKRTIGZSA-N
PubChem Compound ID
5354568
Target and Pathway
Target(s) Fatty-acid amide hydrolase Target Info Inhibitor [529008]
BioCyc Pathway Anandamide degradation
KEGG Pathway Retrograde endocannabinoid signaling
PANTHER Pathway Anandamide degradation
References
Ref 529008J Med Chem. 2007 Oct 4;50(20):5012-23. Epub 2007 Sep 1.Structure-activity relationship of a series of inhibitors of monoacylglycerol hydrolysis--comparison with effects upon fatty acid amide hydrolase.
Ref 529008J Med Chem. 2007 Oct 4;50(20):5012-23. Epub 2007 Sep 1.Structure-activity relationship of a series of inhibitors of monoacylglycerol hydrolysis--comparison with effects upon fatty acid amide hydrolase.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.